DC-SIGN / CD209 Peptide | 43-700P

DC-SIGN / CD209 Peptide | 43-700P | Gentaur UK, US & Europe Distribution

Short Description: N/A

Species: Human

Location: DC-SIGN / CD209 peptide corresponds to 12 amino acids of DC-SIGN / CD209.

Tested Application: Bl

Application: DC-SIGN / CD209 peptide is used for blocking the activity of DC-SIGN / CD209 antibody (catalog number 43-700 ). The DC-SIGN / CD209 antibody ships at 0.5 mg/mL and the STK36 Peptide ships as a 100 ug pellet. When peptide is reconstituted in 200 uL water, the concentration will be 0.5 mg/mL, identical to that of the antibody. The best starting ratio would be 1:1 (which means molar excess of peptide relative to antibody when identical volumes are mixed). Mix equal volume of peptide and antibody at the required dilution and leave at ambient temperature for 20 minutes. Then incubate and develop in parallel two blots: one with the antibody and one with the antibody which has been pre-absorbed with the provided peptide..

Physical State: Lyophilized

Buffer: DC-SIGN / CD209 peptide is supplied as 100 μg of dried peptide. When the peptide is reconstituted in 200 μL water, the concentration will be 0.5 mg/mL.

Concentration: N/A

Storage: Store at -20˚C. When reconstituted minimize freezing and thawing.

NCBI Official Symbol: DC-SIGN / CD209

Alternate Names: CD209, CD209 molecule, CDSIGN, CLEC4L, DC-SIGN, DC-SIGN1, C-type lectin domain family 4 member L, C-type lectin domain family 4, member L, CD209 antigen, HIV gpl20-binding protein, dendritic cell-specific ICAM-3-grabbing non-integrin 1, dendritic cell-spe

NCBI Gene ID: 30835

User Note: N/A

NCBI Official Name: Cd209 Molecule

Background: N/A

Disclaimer: This product is for research use only.